We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFGC icon
226
Performance Food Group
PFGC
$18B
$423K 0.18%
+4,839
New +$403K
NOW icon
227
ServiceNow
NOW
$129B
$423K 0.18%
2,055
-1,905
-48% -$359K
CW icon
228
Curtiss-Wright
CW
$25.5B
$421K 0.18%
861
-1,675
-66% -$661K
CFLT
229
DELISTED
Confluent
CFLT
$420K 0.18%
16,857
-10,097
-37% -$228K
NVDA icon
230
NVIDIA
NVDA
$5.42T
$420K 0.18%
2,659
-2,865
-52% -$361K
DOCN icon
231
DigitalOcean
DOCN
$14.6B
$418K 0.18%
+14,651
New +$428K
FBIN icon
232
Fortune Brands Innovations
FBIN
$6.06B
$418K 0.18%
+8,115
New +$425K
AXS icon
233
AXIS Capital
AXS
$7.55B
$417K 0.18%
4,017
-5,450
-58% -$542K
AR icon
234
Antero Resources
AR
$10.7B
$416K 0.18%
10,317
-3,604
-26% -$136K
MCD icon
235
McDonald's
MCD
$195B
$414K 0.18%
+1,418
New +$437K
RRX icon
236
Regal Rexnord
RRX
$11.9B
$413K 0.18%
+2,850
New +$357K
LOW icon
237
Lowe's Companies
LOW
$125B
$409K 0.18%
1,843
+564
+44% +$126K
LMT icon
238
Lockheed Martin
LMT
$136B
$404K 0.18%
+872
New +$408K
ASAN icon
239
Asana
ASAN
$2.13B
$403K 0.18%
29,847
+19,281
+182% +$302K
HRMY icon
240
Harmony Biosciences
HRMY
$2.24B
$402K 0.17%
+12,719
New +$409K
OVV icon
241
Ovintiv
OVV
$16.4B
$400K 0.17%
+10,512
New +$386K
JCI icon
242
Johnson Controls International
JCI
$92.2B
$398K 0.17%
3,768
-2,286
-38% -$210K
POWL icon
243
Powell Industries
POWL
$7.71B
$398K 0.17%
+5,673
New +$342K
PAYC icon
244
Paycom
PAYC
$9.69B
$397K 0.17%
+1,715
New +$407K
PATK icon
245
Patrick Industries
PATK
$2.85B
$397K 0.17%
+4,299
New +$366K
LPLA icon
246
LPL Financial
LPLA
$28.6B
$395K 0.17%
+1,053
New +$369K
MKC icon
247
McCormick & Company Non-Voting
MKC
$14.2B
$393K 0.17%
5,184
-1,272
-20% -$95.3K
EE icon
248
Excelerate Energy
EE
$1.11B
$392K 0.17%
13,382
+6,314
+89% +$177K
KNX icon
249
Knight Transportation
KNX
$11.4B
$392K 0.17%
8,861
+4,032
+83% +$171K
THG icon
250
Hanover Insurance
THG
$7.98B
$388K 0.17%
2,283
-1,602
-41% -$268K
8 9
10
11 12

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.